Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333260![]() ((2S,3R,4S)-2-(8-((3,5-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333214![]() ((2S,3R,4S)-2-(8-((3-(trifluoromethyl)benzyl)amino)...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333208![]() ((2S,3R,4S)-2-(8-(piperidin-1-yl)-[1,2,4]triazolo[4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333227![]() ((2S,3R,4S)-2-(8-((pyridin-4-ylmethyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333228![]() ((2S,3R,4S)-2-(8-((furan-3-ylmethyl)amino)-[1,2,4]t...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333246![]() ((2S,3R,4S)-2-(8-((4-methylpiperazin-1-yl)amino)-[1...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333259![]() ((2S,3R,4S)-2-(8-(2-(3-chlorophenyl)hydrazinyl)-[1,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333261![]() ((2S,3R,4S)-2-(8-((2,5-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333210![]() ((2S,3R,4S)-2-(8-(benzylamino)-[1,2,4]triazolo[4,3-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333240![]() ((2S,3R,4R)-2-(8-((3-chlorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333238![]() ((2S,3R,4S)-2-(8-((2-morpholinoethyl)amino)-[1,2,4]...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333254![]() ((2S,3R,4S)-2-(8-((4-iodobenzyl)amino)-[1,2,4]triaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333237![]() ((2S,3R,4S)-2-(8-(isopentylamino)-[1,2,4]triazolo[4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333215![]() ((2S,3R,4S)-2-(8-((thiophen-3-ylmethyl)amino)-[1,2,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333230![]() ((2S,3R,4S)-2-(8-((3-bromophenethyl)amino)-[1,2,4]t...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333258![]() ((2S,3R,4S)-2-(8-hydroxy-[1,2,4]triazolo[4,3-a]pyra...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333226![]() ((2S,3R,4S)-2-(8-((pyridin-3-ylmethyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333232![]() ((2S,3R,4S)-2-(8-((2-phenylcyclopropyl)amino)-[1,2,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333243![]() ((2S,3R,4R)-2-(8-((3-iodobenzyl)amino)-[1,2,4]triaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333250![]() ((2S,3R,4S)-2-(8-(((S)-1-(3-chlorophenyl)ethyl)amin...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333262![]() ((2S,3R,4S)-2-(8-((thiophen-2-ylmethyl)amino)-[1,2,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333211![]() ((2S,3R,4S)-2-(8-((3-iodobenzyl)amino)-[1,2,4]triaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333217![]() ((2S,3R,4S)-2-(8-((3-methylbenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333247![]() ((2S,3R,4S)-2-(8-(morpholinoamino)-[1,2,4]triazolo[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333212![]() ((2S,3R,4S)-2-(8-((cyclopropylmethyl)amino)-[1,2,4]...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333221![]() (3-(((3-((2S,3R,4S)-3,4-dihydroxytetrahydrothiophen...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333239![]() (3-chloro-N-(3-((2S,3R,4S)-3,4-dihydroxytetrahydrot...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333174![]() ((2S,3R,4S)-2-(8-((3-chlorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333216![]() ((2S,3R,4S)-2-(8-(phenethylamino)-[1,2,4]triazolo[4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333244![]() ((2S,3R,4R)-2-(8-((3-chlorophenethyl)amino)-[1,2,4]...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333252![]() ((2S,3R,4S)-2-(8-((2-chlorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333233![]() ((2S,3R,4S)-2-(8-((2-(3-chlorophenyl)propan-2-yl)am...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333209![]() ((2S,3R,4S)-2-(8-morpholino-[1,2,4]triazolo[4,3-a]p...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333225![]() ((2S,3R,4S)-2-(8-(cyclohexylamino)-[1,2,4]triazolo[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333222![]() ((2S,3R,4S)-2-(8-((3-bromobenzyl)amino)-[1,2,4]tria...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333245![]() (4-(((3-((2S,3R,4S)-3,4-dihydroxytetrahydrothiophen...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333224![]() ((2S,3R,4S)-2-(8-(cyclopentylamino)-[1,2,4]triazolo...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333263![]() ((2S,3R,4S)-2-(8-((2,3-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333241![]() ((2S,3R,4S)-2-(8-((imidazo[1,2-a]pyridin-2-ylmethyl...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333236![]() ((2S,3R,4S)-2-(8-(cyclopropylamino)-[1,2,4]triazolo...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333220![]() ((2S,3R,4S)-2-(8-((3-methoxybenzyl)amino)-[1,2,4]tr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333256![]() ((2S,3R,4S)-2-(8-((2-(piperidin-1-yl)ethyl)amino)-[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333249![]() (2-chloro-4-(((3-((2S,3R,4S)-3,4-dihydroxytetrahydr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333265![]() ((2S,3R,4S)-2-(8-((2,4-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333218![]() ((2S,3R,4S)-2-(8-((3-fluorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333207![]() ((2S,3R,4S)-2-(8-(methylamino)-[1,2,4]triazolo[4,3-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333264![]() ((2S,3R,4S)-2-(8-((3,4-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333248![]() ((2S,3R,4S)-2-(8-(((1S,2R)-2-phenylcyclopropyl)amin...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333234![]() ((2S,3R,4S)-2-(8-((1-(3-chlorophenyl)cyclopropyl)am...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333213![]() ((2S,3R,4S)-2-(8-(cyclobutylamino)-[1,2,4]triazolo[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 240 total ) | Next | Last >> |